Molecular Point Of Care Testing (Using NAAT) Market Outlook Industry Share, Growth, Drivers, Emerging Technologies, and Forecast Research Report 2029
Description
molecular
point of care testing (using NAAT) market is expected to
reach USD 62,553.67 million by 2029 , from USD 25,170.05 million in 2020,
growing at the CAGR of 10.8% in the forecast period of 2021 to 2029 . The
global molecular point of care testing (using NAAT) market is expected to grow
due to improving healthcare facilities and infrastructures and the adoption of
end-of-care testing at the hospital, laboratories, and clinics, which can drive
the market's growth. The other factors anticipated to propel the development of
the molecular point of care testing (using NAAT) market include the rising
prevalence of infectious diseases. The other factors, such as the lack of
skilled professionals and the high cost of customized molecular point-of-care
testing (using NAAT), hamper the growth of the global molecular end-of-care
testing (using NAAT) market. On the other hand, the increased healthcare
expenditure and emerging countries with developed hospitals act as an
opportunity to grow the global molecular point of care testing (using NAAT)
market.
Molecular Point of Care Testing (using NAAT) Market
Analysis and Insights
The leading
MOLECULAR POINT OF CARE TESTING (USING NAAT) market report eases the process of
acquiring valuable market insights with the new skills, latest tools and
innovative programs, which is sure to aid in achieving business goals. POCT is
characterized as testing which can be done close to the patient where a medical
decision can be made immediately, including the results and monitoring. POCT
devices now entering clinical use are based on nucleic acid amplification
technologies (NAAT), defined here as second-generation devices. These platforms
generally have improved sensitivity, typically 60 to 90%, compared to
first-generation POCTs, and require portable instrumentation with a footprint
of approximately 30cm x 30cm. These instruments are essentially used in
molecularly detecting various disorders such as HIV, HPV,
and respiratory disease through NAAT technology. NAAT is Nucleic Acid
Amplification Techniques that allow the identification of pathogenic organisms
by detecting their DNA or RNA.
Request Access for Molecular Point Of Care
Testing (Using NAAT) Market
Sample Report:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=-molecular-point-of-care-testing-using-naat-market
Molecular Point Of Care
Testing (Using NAAT) Market Scope And Market Size
With the increase in the successful diagnosis of
chronic diseases, including cancer, anemia, type 2 diabetes, and others, the
improved health care professionals provide regular training sessions for the
professionals for conducting tests in account for the improvement of diagnosis
rate in the region. With the increase in the burden of diseases, the diagnosis
rate is also increasing. With the advancements in the diagnosis, the rate is
also growing for people going through the diagnosis.
- On the basis of distribution channel, the molecular point of care testing (using
NAAT) market is segmented into direct tender, third party distributor,
online sales. In 2021, the direct sales segment in the molecular point of
care testing (using NAAT) market is expected to grow due to the increased
demand for advanced technologies and testing requirements in medical care
for operations and diagnosis.
- On the basis of product, the molecular point
of care testing (using NAAT) market is segmented into instruments,
consumables, and reagents. In 2021, the consumables & reagents segment
in the molecular point of care testing (using NAAT) market is expected to
grow due to changing lifestyles and increasing chronic diseases, and
increasing awareness of over-the-counter NAAT-based POCT devices.
- On the basis of end user, the molecular point
of care testing (using NAAT) market is segmented into laboratories,
hospitals, clinics, ambulatory centers, home care, assisted living
facilities, and others. In 2021, the laboratories segment in the molecular
point of care testing (using NAAT) market is expected to dominate because
of the high preference of POCT testing being recommended to laboratories
as they are fully focused on the diagnosis of the various disorder.
Get TOC of the Report:
https://www.databridgemarketresearch.com/toc/?dbmr=-molecular-point-of-care-testing-using-naat-market
Major TOC of the Molecular
Point Of Care Testing (Using NAAT) Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Access Full Report:- https://www.databridgemarketresearch.com/reports/-molecular-point-of-care-testing-using-naat-market
Molecular Point Of Care Testing (Using NAAT) Market Country Level
Analysis
Data points such as new sales,
replacement sales, country demographics, regulatory acts, and import-export
tariffs are some of the major pointers used to forecast the market scenario for
individual countries. Also, the presence and availability of brands and their challenges faced due to
large or scarce competition from local and domestic brands, the impact of sales
channels are considered while providing forecast analysis of the country
data.
Competitive Landscape and Molecular Point Of Care Testing (Using
NAAT) Market Share Analysis
Increasing healthcare expenditure and
infrastructure can help patients take hassle-free advanced treatment to receive
better diagnoses, procedures, and treatment for fast recovery. Point-of-care
testing devices are beneficial for detecting various diseases and supporting
treatment plans using POC software and solutions. Healthcare spending comprises
out-of-pocket payments (people paying for their care), government expenditure,
and sources including health insurance and activities by non-governmental
organizations.
U.S. is expected to dominate
the molecular point of care testing (using NAAT) market because of the
increasing diagnosis rate and awareness about chronic disease. U.K. is expected
to molecular point of care testing (using NAAT) market due to increased
procurement of advanced technologies available for molecular POCT. India in
South Asia region is expected to
molecular point of care testing (using NAAT) market due to the presence
of huge potential for procurement of product and rising healthcare.
Some of the major companies providing molecular point of care testing
(using NAAT) products in the molecular
point of care testing (using NAAT) market are
·
Thermo Fisher Scientific Inc.,
·
Hologic, Inc.,
·
BD, F. Hoffmann-La Roche Ltd,
·
binx health, inc.,
·
Sysmex (A Subsidiary of Sysmex
Corporation),
·
Co-Diagnostics, Inc.,
·
ABBOTT, Seegene Inc.,
·
bioMérieux SA,
·
QIAGEN,
·
Bio-Rad Laboratories, Inc.,
·
PerkinElmer Inc.,
·
Grifols,
·
S.A.,
·
Quidel Corporation,
·
GenMark Diagnostics, Inc.,
·
SD Biosensor, INC.,
·
Oxford Nanopore Technologies,
·
Wondfo,
·
Randox Laboratories Ltd.,
·
Meridian Bioscience,
·
Sekisui Diagnostics,
·
QuantuMDx Group Ltd.,
·
Lucira Health Inc.,
· Danaher,
Browse Related Reports @
Global Single Use Medical Devices Reprocessing Market
Europe Single Use Medical Devices Reprocessing Market
Asia-Pacific Single Use Medical Devices Reprocessing Market
Middle East and Africa Single Use Medical Devices Reprocessing
Market
North America Single Use Medical Devices Reprocessing Market
Global Electronic Clinical Outcome Assessment (eCOA) for Content
Licensed Market
Europe Electronic Clinical Outcome Assessment (eCOA) for Content
Licensed Market
About Us:
Data Bridge Market Research set forth itself as an unconventional
and neoteric Market research and consulting firm with unparalleled level of
resilience and integrated approaches. We are determined to unearth the best
market opportunities and foster efficient information for your business to
thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Comments
Post a Comment